ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care
Transplant International · 14.10.2024 · 37
DOI: 10.3389/ti.2024.13485 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant International, online erschienen am 14.10.2024. Verfasst von Ekaterine Berishvili und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cell Isolation and Transplantation Centre, Department of Surgery, Geneva University Hospitals, Laboratory of Tissue Engineering and Organ Regeneratio…. Hauptthemen laut MEDLINE: Cell- and Tissue-Based Therapy, Genetic Therapy, Health Services Accessibility, Organ Transplantation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The field of organ transplantation is experiencing a transformative shift with the rise of Advanced Therapy Medicinal Products (ATMPs), which include gene therapies, somatic cell therapies, and tissue-engineered products. These therapies offer new, potentially curative treatments for longstanding medical challenges, impacting numerous patients. However, their adoption is hindered by complex regulatory frameworks, high production costs, and inconsistent access across Europe. The ESOT ATMP Task Force’s position paper analyzes these challenges from research to clinical application, advocating for a coordinated strategy to position Europe as a leader in ATMP development. It proposes specific actions such as streamlining regulatory pathways to accelerate approvals, boosting funding for ATMP research, and creating specialized facilities for development and implementation. The paper also highlights the critical roles of patient engagement and real-world evidence in optimizing clinical and regulatory practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cell Isolation and Transplantation Centre, Department of Surgery, Geneva University Hospitals, Laboratory of Tissue Engineering and Organ Regeneration, Department of Surgery, University of Geneva, Geneva, Switzerland.
- Diabetes Research Institute, IVita-Salute San Raffaele University, Milan, Italy.
- Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands.
- Department of Clinical Sciences, Lund University, Lund, Sweden.
- Lund Stem Cell Center, Lund University, Lund, Sweden.
- Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Zitieren
APA
Berishvili, E., Piemonti, L., de Koning, E. J. P., Lindstedt, S., Scholz, H., Scott, W. E., Auxenfans, C., Johnson, P., Martin, D. E., Gunther, P., Mey, D., Potena, L., & Thaunat, O. (2024). ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care. Transplant International, 37. https://doi.org/10.3389/ti.2024.13485
Vancouver
Berishvili E, Piemonti L, de Koning EJP, Lindstedt S, Scholz H, Scott WE, et al. ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care. Transplant International. 2024;37. doi:10.3389/ti.2024.13485
BibTeX
@article{Berishvili2024,
author = {Berishvili, Ekaterine and Piemonti, Lorenzo and de Koning, Eelco J P and Lindstedt, Sandra and Scholz, Hanne and Scott, William E and Auxenfans, Celine and Johnson, Paul and Martin, Dominique E and Gunther, Penilla and Mey, Devi and Potena, Luciano and Thaunat, Olivier},
title = {ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care},
journal = {Transplant International},
year = {2024},
volume = {37},
doi = {10.3389/ti.2024.13485}
}
EUVIMED